Swiss Investment Fund
for Emerging Markets

Portfolio Explorer

Our impactful investments covering a broad range of countries and sectors.

Portfolio Explorer

Our impactful investments covering a broad range of countries and sectors.

BioVeda China Fund III
BioVeda China Fund (BVCF) III L.P is a USD 188m private equity fund that invests in Chinese life sciences and healthcare growth companies. The fund is expected to commit to 12-15 companies, with ticket sizes over multiple rounds ranging typically from USD 5m - 30m. Target companies will be focused primarily on (i) pharmaceuticals/medicines products and delivery, (ii) medical technology devices, and (iii) bio-industrial and environmental technology with enterprise values ranging from USD 30m - 100m. The fund will seek to develop specifically innovative drugs and medical technology devices for the Chinese healthcare system and the healthcare delivery markets, which are servicing the broad majority of the population.
About the Investee

BVCF III is the third fund of BVCF Management Ltd., a seasoned pioneer in healthcare investment management in China, headquartered in Shanghai, with an additional office in Beijing. The fund manager is led by former scientists Dr. Zhi Yang and Dr. Yi (Robert) Li, and works closely with its investee companies in the areas of business development, sales & marketing and strategy.

SIFEM committed USD 8m to the Fund and joins DFI investor IFC, as well as strategic and financial investors.
Investments by the Fund (as of 2023-12)
Name Year Country Industry Status
Jiyuan 2017 China Healthcare services Active
WeKair 2017 China Healthcare services Active
AcuVu 2017 China Medical equipment Active
VivaLnk 2016 China Pharmaceuticals and biotech Active
Accelerix International (Drug Farm) 2016 China Pharmaceuticals and biotech Active
Accelerix International (SofMat) 2015 United Kingdom* Pharmaceuticals and biotech Active
First Dimension Biosciences 2015 China Pharmaceuticals and biotech Active
Beijing Shiguang Caibei 2014 China Pharmaceuticals and biotech Active
Yidu Health 2014 China Healthcare services Active
Extong Technology 2014 China Pharmaceuticals and biotech Active
Jaguar Animal Health 2014 United States* Pharmaceuticals and biotech Active
RiboQuark 2013 China Pharmaceuticals and biotech Active
MicuRx 2013 China Pharmaceuticals and biotech Active
Yashen Tech 2013 China Chemicals and chemical products Active
Visunex 2013 China Healthcare services Active
Note: Countries with an * are countries from which services are provided in emerging and developing countries. Please refer to our Data Taxonomy page for details on the nature and quality of the information we publish.
Reference code
12-090
Status
Active
Date of commitment
2012-08
Fund size
USD 226 million
SIFEM commitment
USD 8 million
Portfolio
Own balance sheet
Concessional finance
0%
Asset class
Private Equity
Type
Fund
ESG Risk Categories
Environmental & Social: B
Governance: -
Instrument
Private Equity Fund
Target region
Asia
Target sector
Healthcare
Related Transaction
2018: BVCF Realization Fund
Manager
BioVeda China Managing Partners